HSA
IONS icon

Hussman Strategic Advisors’s Ionis Pharmaceuticals IONS Stock Holding History

Hussman Strategic Advisors’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-7,200
Closed -$287K – 335
2021
Q2 		$287K Hold
7,200
– – 0.06% 304
2021
Q1 		$324K Buy
+7,200
New +$402K 0.07% 292
2020
Q3 		– Sell
-25,000
Closed -$1.47M – 283
2020
Q2 		$1.47M Hold
25,000
– – 0.38% 102
2020
Q1 		$1.18M Buy
+25,000
New +$1.39M 0.32% 129

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Hussman Strategic Advisors's IONS Position: Q3 2021 in Review

Hussman Strategic Advisors sold out of Ionis Pharmaceuticals (IONS) in Q3 2021, closing a stake of 7,200 shares — an estimated $287K sold.

Hussman Strategic Advisors first reported a position in IONS in Q1 2020 and held it in 4 quarters. The position peaked at $1.47M in Q2 2020. 324 funds tracked by Wall St. Rank hold IONS as of Q3 2021.

  • Hussman Strategic Advisors reported no remaining Ionis Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
  • Hussman Strategic Advisors sold 7,200 Ionis Pharmaceuticals shares in Q3 2021, an estimated $287K.
  • Hussman Strategic Advisors first reported a position in Ionis Pharmaceuticals in Q1 2020 and held it in 4 quarters.
  • Hussman Strategic Advisors's Ionis Pharmaceuticals position peaked at $1.47M in Q2 2020.
  • 324 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q3 2021.

Based on Hussman Strategic Advisors's 13F filing for Q3 2021, filed 1 Nov 2021.